IQV
IQVIA HOLDINGS INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$265.88
−0.38%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$268.10
From 52W high−3.32%
Volume831975.00
Market cap$43.76B
P/E (TTM)32.7x
P/S (TTM)2.6x
Div yield—
Key dataOct 19, 2026
Open
$268.10
From 52W high
−3.32%
Volume
831975.00
Market cap
$43.76B
ValuationView details →
P/E (Fwd)
19.0x
EV/EBITDA
16.5x
P/E (TTM)
32.7x
RSI (14)
52.8
MomentumView details →
1D Return
−0.38%
YTD Return
+17.68%
SummaryUpdated Jun 1, 2026
IQVIA Holdings Inc. (NASDAQ:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Founded in 1982 and originally known as Quintiles IMS Holdings, the company changed its name to IQVIA in November 2017. Headquartered in Durham, North Carolina, IQVIA was formed through the merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data and analytics company). Today, the company operates across the Americas, Europe, Africa, and the Asia-Pacific region, serving pharmaceutical, biotechnology, device and diagnostic, and consumer health companies worldwide.
Similar companies
Latest newsMore news →
IQVIA HOLDINGS INC. and VEEVA SYSTEMS INC announced an extension of their partnership, with IQVIA HOLDINGS INC. selecting Veeva CTMS and eTMF applications.6d agoThe Pioneer Institute and CancerCare released an analysis of nearly 4,000 hospitals finding that 340B program participants spent 2.16% of operating expenses on charity care versus 2.82% at non-participating hospitals.21d ago